US FDA approves Johnson & Johnson’s device for heart condition
By Thomson ReutersNov 7, 2024 | 7:18 AM
(Reuters) – The U.S. Food & Drug Administration has approved Johnson & Johnson’s device for a type of heart condition, the company said on Thursday.
(Reporting by Sriparna Roy in Bengaluru; Editing by Shounak Dasgupta)
For the health and safety of everyone, our offices are temporarily closed to the public. If you have won a prize from us we will be mailing it to you or will contact you with specific information needed to redeem your prize. Feel free to call us with questions during weekday business hours at 715-842-1672.
